Inventor · disambiguated record
Gerald S. Brenner
Also filed as: BRENNER GERALD · BRENNER GERALD S · DEMARCO JOSEPH
12 granted patents·2 pending applications·274 citations·filing 1978–2024
92Inventor score
Top patents by PatentIndex Score
14 records- 0190US11091505B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·4 cites·19 claims
- 0290US5462932AOral liquid alendronate formulationsMERCK & CO INC·Filed 1994·Granted Oct 31, 1995·102 cites·25 claims
- 0389US4190655AAmiloride citrateMERCK & CO INC·Filed 1978·Granted Feb 26, 1980·18 cites·4 claims
- 0487US11820784B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Nov 21, 2023·1 cites·20 claims
- 0584US12187752B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·15 claims
- 0683US2025320235A1Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0774US5849726AAnhydrous alendronate monosodium salt formulationsMERCK & CO INC·Filed 1996·Granted Dec 15, 1998·40 cites·7 claims
- 0869US5780455AIntravenous alendronate formulationsMERCK & CO INC·Filed 1994·Granted Jul 14, 1998·20 cites·3 claims
- 0966US5356887APharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acidsMERCK & CO INC·Filed 1993·Granted Oct 18, 1994·38 cites·20 claims
- 1062US6008207AAnhydrous alendronate monosodium salt formulationsMERCK & CO INC·Filed 1998·Granted Dec 28, 1999·26 cites·4 claims
- 1162US5914323AIntravenous alendronate formulationsMERCK & CO INC·Filed 1998·Granted Jun 22, 1999·16 cites·1 claims
- 1251US5843924AIntravenous alendronate formulationsMERCK & CO INC·Filed 1998·Granted Dec 1, 1998·8 cites·7 claims
- 1337US5693812APolymorphic forms of an angiotensin II antagonistMERCK & CO INC·Filed 1996·Granted Dec 2, 1997·1 cites·22 claims
- 1435US2001021705A1Disodium alendronate formulationsMERCK & CO INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerald S. Brenner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →